10x Genomics to Report Fourth Quarter and Full Year 2019 Financial Results on February 18, 2020
February 04 2020 - 4:05PM
10x Genomics (Nasdaq: TXG) today announced it will report financial
results for the fourth quarter and full year ended December 31,
2019 after market close on Tuesday, February 18, 2020. Company
management will host a corresponding conference call beginning at
1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its
results, business developments and outlook.
Analysts, investors and other parties interested in listening to
the conference call may do so by dialing (877) 665-6515 for
domestic callers or (602) 563-8470 for international callers, using
conference ID: 59416276. A live and archived webcast of the event
will be available at https://investors.10xgenomics.com/ for at
least 45 days following the event.
About 10x Genomics10x Genomics is a life
science technology company building products to interrogate,
understand and master biology to advance human health. The
company’s integrated solutions include instruments, consumables and
software for analyzing biological systems at a resolution and scale
that matches the complexity of biology. 10x Genomics products have
been adopted by researchers around the world including 96 of the
top 100 global research institutions and 19 of the top 20 global
pharmaceutical companies, and have been cited in over 700 research
papers on discoveries ranging from oncology to immunology and
neuroscience. The company's patent portfolio comprises more than
700 issued patents and patent applications.
Disclosure Information10x Genomics uses filings
with the Securities and Exchange Commission, its website
(www.10xgenomics.com), press releases, public conference calls,
public webcasts and its social media accounts as means of
disclosing material nonpublic information and for complying with
its disclosure obligations under Regulation FD.
ContactsInvestorsinvestors@10xgenomics.com
Mediamedia@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jun 2024 to Jul 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jul 2023 to Jul 2024